Attention related electrophysiological waves, such as P300, often deviate from norm in various populations of neuropsychiatric patients. For example, the amplitude is often smaller and the latency is often longer in major depressive disorder, in bipolar disorder and in schizophrenia. On the other hand, in other neuropsychiatric populations, it is often possible to note the opposite phenomena of larger P300 amplitude and shorter latency in comparison with norm, but only for a specific subset of stimuli. This is often reported in various anxiety disorders, substance abuse and various chronic pain syndromes. These findings in the various clinical populations, on their commonalities and differences, are presented in this work. The prevalence of these two types of deviations in the electrophysiological markers of attention, shared by multiple neuropsychiatric populations, raise interesting questions regarding the role of attention deviation and regulation in neuropsychiatry. We present these questions and outline a possible hypothesis in this regard. Furthermore, such potential sensitivity of the attention-related markers to clinical dynamics suggests they could be candidates for monitoring and, potentially, early-sensing of clinical dynamics. Therefore, we discuss the potential usability of such markers.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11126-019-09664-x | DOI Listing |
Nat Rev Dis Primers
January 2025
Endocrine Division, Department of Medicine, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Québec, Canada.
Cushing syndrome (CS) is a constellation of signs and symptoms caused by excessive exposure to exogenous or endogenous glucocorticoid hormones. Endogenous CS is caused by increased cortisol production by one or both adrenal glands (adrenal CS) or by elevated adrenocorticotropic hormone (ACTH) secretion from a pituitary tumour (Cushing disease (CD)) or non-pituitary tumour (ectopic ACTH secretion), which stimulates excessive cortisol production. CS is associated with severe multisystem morbidity, including impaired cardiovascular and metabolic function, infections and neuropsychiatric disorders, which notably reduce quality of life.
View Article and Find Full Text PDFFront Cell Neurosci
January 2025
Reserach Unit "Drosophila"UR22ES03, Faculty of Medicine, University of Sfax, Sfax, Tunisia.
Background: The human gut mycobiome, a minor but integral component of the gut microbiome, has emerged as a significant player in host homeostasis and disease development. While bacteria have traditionally been the focus of gut microbiome studies, recent evidence suggests that fungal communities (mycobiota) may also play a crucial role in modulating health, particularly in neuropsychiatric disorders.
Objective: This review aims to provide a comprehensive overview of current knowledge on the relationship between the gut mycobiome and neuropsychiatric disorders, exploring the potential of targeting fungal communities as a novel therapeutic strategy.
J Child Psychol Psychiatry
February 2025
Wolfson Centre for Young People's Mental Health, Cardiff University, Cardiff, UK.
In this editorial, I reflect on the implications of social, technological and cultural change for children and young people. Whilst we have a reasonably good understanding of trends in certain aspects of child development (e.g.
View Article and Find Full Text PDFNature
January 2025
Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Bipolar disorder is a leading contributor to the global burden of disease. Despite high heritability (60-80%), the majority of the underlying genetic determinants remain unknown. We analysed data from participants of European, East Asian, African American and Latino ancestries (n = 158,036 cases with bipolar disorder, 2.
View Article and Find Full Text PDFJAMA Psychiatry
January 2025
Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Importance: Depressive symptoms are associated with cognitive decline in older individuals. Uncertainty about underlying mechanisms hampers diagnostic and therapeutic efforts. This large-scale study aimed to elucidate the association between depressive symptoms and amyloid pathology.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!